Antibacterial Activity of BSA-Capped Gold Nanoclusters against Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) and Vancomycin-Intermediate <i>Staphylococcus aureus</i> (VISA)

<div>Time-killing curves of BSA-AuNCs against (a) MRSA (ATCC® 33592™), (b) MRSA (ATCC® 49476™), (c) VISA mu3 (ATCC® 700698™), and (d) VISA mu50 (ATCC® 700699™).</div>

Journal of Nanomaterials

fig3

Figure 3

Figure 3: Antibacterial Activity of BSA-Capped Gold Nanoclusters against Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) and Vancomycin-Intermediate <i>Staphylococcus aureus</i> (VISA) 

Figure 3 | Antibacterial Activity of BSA-Capped Gold Nanoclusters against Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Intermediate Staphylococcus aureus (VISA) 